Naobios receives $1.87 million to fund human viral challenge agent

Naobios receives $1.87 million to fund human viral challenge agent

Source: 
Biopharma Reporter
snippet: 

Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based products, has received a $1.87 million grant from the Bill & Melinda Gates Foundation to support its vaccine development efforts.